Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Neuromodulation Treatments for Schizophrenia.

Dokucu ME.

Curr Treat Options Psychiatry. 2015 Sep;2(3):339-348. doi: 10.1007/s40501-015-0055-4. Epub 2015 Jul 3.

2.

Decreased Expression of α-Synuclein, Nogo-A and UCH-L1 in Patients with Schizophrenia: A Preliminary Serum Study.

Demirel ÖF, Cetin İ, Turan Ş, Sağlam T, Yıldız N, Duran A.

Psychiatry Investig. 2017 May;14(3):344-349. doi: 10.4306/pi.2017.14.3.344. Epub 2017 May 16.

3.

Reduced functional connectivity between bilateral precuneus and contralateral parahippocampus in schizotypal personality disorder.

Zhu Y, Tang Y, Zhang T, Li H, Tang Y, Li C, Luo X, He Y, Lu Z, Wang J.

BMC Psychiatry. 2017 Feb 2;17(1):48. doi: 10.1186/s12888-016-1146-5.

4.

Iloperidone in the treatment of schizophrenia: an evidence-based review of its place in therapy.

Tonin FS, Wiens A, Fernandez-Llimos F, Pontarolo R.

Core Evid. 2016 Dec 14;11:49-61. doi: 10.2147/CE.S114094. eCollection 2016. Review.

5.

Characterization of the Fiber Connectivity Profile of the Cerebral Cortex in Schizotypal Personality Disorder: A Pilot Study.

Liu K, Zhang T, Zhang Q, Sun Y, Wu J, Lei Y, Chu WC, Mok VC, Wang D, Shi L.

Front Psychol. 2016 May 30;7:809. doi: 10.3389/fpsyg.2016.00809. eCollection 2016.

6.

Reduced Theta-Band Power and Phase Synchrony during Explicit Verbal Memory Tasks in Female, Non-Clinical Individuals with Schizotypal Traits.

Choi JW, Jang KM, Jung KY, Kim MS, Kim KH.

PLoS One. 2016 Feb 3;11(2):e0148272. doi: 10.1371/journal.pone.0148272. eCollection 2016.

7.

Severity of Cortical Thinning Correlates With Schizophrenia Spectrum Symptoms.

Watsky RE, Pollard KL, Greenstein D, Shora L, Dillard-Broadnax D, Gochman P, Clasen LS, Berman RA, Rapoport JL, Gogtay N, Ordóñez AE.

J Am Acad Child Adolesc Psychiatry. 2016 Feb;55(2):130-136. doi: 10.1016/j.jaac.2015.11.008. Epub 2015 Nov 26.

8.

Drug Addiction in Patients With Chronic Schizophrenia and Its Relation With Psychopathology and Impulsiveness.

Shokrgozar S, Ahmadi R, Yousefnezhad A, Roshandelrad M, Khosravi T, Ellahi M, Pakdaman M, Eskandari A.

Glob J Health Sci. 2015 Mar 26;7(7 Spec No):131-6. doi: 10.5539/gjhs.v7n7p131.

9.

Examining the Psychosis Continuum.

DeRosse P, Karlsgodt KH.

Curr Behav Neurosci Rep. 2015 May 1;2(2):80-89.

10.

Deficits in error-monitoring by college students with schizotypal traits: an event-related potential study.

Kim SH, Jang KM, Kim MS.

PLoS One. 2015 Mar 31;10(3):e0122861. doi: 10.1371/journal.pone.0122861. eCollection 2015.

11.

Cognition and brain function in schizotypy: a selective review.

Ettinger U, Mohr C, Gooding DC, Cohen AS, Rapp A, Haenschel C, Park S.

Schizophr Bull. 2015 Mar;41 Suppl 2:S417-26. doi: 10.1093/schbul/sbu190. Review.

12.

POSITIVE AND NEGATIVE SUBCLINICAL SYMPTOMS AND MCCB PERFORMANCE IN NON-PSYCHIATRIC CONTROLS.

Korponay C, Nitzburg GC, Malhotra AK, DeRosse P.

Schizophr Res Cogn. 2014 Dec 1;1(4):175-179.

13.

Sensory gating disturbances in the spectrum: similarities and differences in schizotypal personality disorder and schizophrenia.

Hazlett EA, Rothstein EG, Ferreira R, Silverman JM, Siever LJ, Olincy A.

Schizophr Res. 2015 Feb;161(2-3):283-90. doi: 10.1016/j.schres.2014.11.020. Epub 2014 Dec 5.

14.

Evidence from structural and diffusion tensor imaging for frontotemporal deficits in psychometric schizotypy.

DeRosse P, Nitzburg GC, Ikuta T, Peters BD, Malhotra AK, Szeszko PR.

Schizophr Bull. 2015 Jan;41(1):104-14. doi: 10.1093/schbul/sbu150. Epub 2014 Nov 11.

15.

Common variants in the MKL1 gene confer risk of schizophrenia.

Luo XJ, Huang L, Oord EJ, Aberg KA, Gan L, Zhao Z, Yao YG.

Schizophr Bull. 2015 May;41(3):715-27. doi: 10.1093/schbul/sbu156. Epub 2014 Nov 7.

16.

Pharmacological interventions for schizotypal personality disorder.

Farooq S, Völlm BA, Husain N, Huband N, Stoffers J, Gibbon S, Duggan C, Ferriter M, Lieb K.

Cochrane Database Syst Rev. 2011;(3). pii: CD009047.

17.

Schizophrenia: overview and treatment options.

Patel KR, Cherian J, Gohil K, Atkinson D.

P T. 2014 Sep;39(9):638-45.

18.

White matter abnormalities in schizophrenia and schizotypal personality disorder.

Lener MS, Wong E, Tang CY, Byne W, Goldstein KE, Blair NJ, Haznedar MM, New AS, Chemerinski E, Chu KW, Rimsky LS, Siever LJ, Koenigsberg HW, Hazlett EA.

Schizophr Bull. 2015 Jan;41(1):300-10. doi: 10.1093/schbul/sbu093. Epub 2014 Jun 23.

19.

Prefrontal dopamine D1 receptors and working memory in schizotypal personality disorder: a PET study with [¹¹C]NNC112.

Thompson JL, Rosell DR, Slifstein M, Girgis RR, Xu X, Ehrlich Y, Kegeles LS, Hazlett EA, Abi-Dargham A, Siever LJ.

Psychopharmacology (Berl). 2014 Oct;231(21):4231-40. doi: 10.1007/s00213-014-3566-6. Epub 2014 Apr 30.

20.

Spatial analysis of schizotypal personality traits in Chinese male youths: evidence from a GIS-based analysis of Sichuan.

Zhang J, Wang W, Tan Z, Wu Q, Xiao W, Shang L, Zhang Y, Peng J, Miao D.

Int J Ment Health Syst. 2014 Jan 15;8(1):3. doi: 10.1186/1752-4458-8-3.

Supplemental Content

Support Center